AJANTPHARM / Q2-FY26 / claim-ledger

Audit the questions that mattered.

Ajanta Pharma · Analyst questions, management answers, and the quality of the response where the ledger is available.

Research layer active

ConCallIQ research layer

Signal, with the source still visible.

Use the controls below to narrow the view, then follow the evidence into the next layer of context.

PositiveQ2-FY26 · 2025-11-07Back to quarter ↗

Questions audited

11

Answered directly

55%

Numeric claims

4

Consistency

contradicted

Question ledger

What was answered, and how?

Tushar Manudhane · Motilal Oswal

partial

Why fewer new launches in domestic formulation H1 FY26? Outlook for H2 and FY27?

I think they have been very selective and strategic in nature. We have fulfilled the gaps wherever we have felt that there is a need for a new product launch. And this trend will continue even for the second half of the year.

Tushar Manudhane · Motilal Oswal

partial

US growth outlook for FY27-28 given R&D spend?

I think FY 2027 and 2028, probably let's talk a little later in the year. But we believe that U.S. going forward also should perform well. We should go maybe in high teens growth for sure next year.

Bino Pathiparampil · Elara Capital

direct

Nature of forex loss and full-year margin guidance?

See, we do hedging of our outstanding or export sales, so that hedging, because the euro moved very sharply during this first half, so because of that, the mark-to-market losses have been booked there...

Abdulkader Puranwala · ICICI Securities

partial

Why cautious margin view despite robust top-line growth?

See, what is happening is that the top-line growth is very robust, as you rightly said. Very true. But we are also simultaneously investing on people and products. That is something which is very, very important.

Abdulkader Puranwala · ICICI Securities

direct

Reason for working capital increase and trade receivables?

See, last year, we did factoring for our receivables in the U.S. This factoring was done in Q3 at that time. Somehow, we found that the interest cost for working capital is much better. We will get the advantage. So we switched over from factoring to working capital.

Bharat Celly · Equirus

partial

When will new MR investments start contributing to margins?

I think, let's say, about one, one and a half to two years because to optimize the productivity of the new teams, especially in the new segments, it will take some time.

Bharat Celly · Equirus

evasive

Can margins return to 30% in two years?

I think probably if you compare Ajanta's margins or margins with the rest of the pharma companies, we probably are one of the top three or top five companies who have this kind of margins. So I think the correct way to look at would be to see what is the growth we are posting on the top line and the bottom line.

Bharat Celly · Equirus

partial

How many MRs to be added in next 18-24 months?

In the domestic, we don't have any particular ballpark or number set. We will decide as we go along based on the need and the growth in the existing divisions. But however, we can, I mean, broadly going by the past trend, maybe we can look at about a couple of hundred in the next one and a half to two years.

Abhishek Jain · AlfAccurate Advisors

direct

Number of MRs in India and Asia/Africa?

We now currently have total 5,680 people, both India and Indian markets put together as of today. India is 3,600 people, and Asia, Africa, it is 2,080 people.

Abhishek Jain · AlfAccurate Advisors

declined

Segment-wise EBITDA margin by geography?

No, we don't give geographical EBITDA margin. Sorry for that.

Tushar Manudhane · Motilal Oswal

direct

Reason for switching from factoring model and sustainability?

Yes. I think we will continue this structure now because this is little advantageous in terms of the interest rate. So we are getting a benefit of at least 2%-3% compared to factoring.

Alok Dalal · Jefferies India Private Limited

partial

Why better growth in Africa region? Can double-digit sustain next year?

Generally, the way we are seeing the trends, I think we feel for the next two quarters, our growth should be better than what we had guided earlier. ... Africa, we are looking at a double-digit growth for the next year.